Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
youhou's Profile
Displaying 51-66 of 66 result(s).
GNBTQ Generex Biotechnology Corp.
05/24/2021 4:10:20 PM
You should be able to access the OT
GNBTQ Generex Biotechnology Corp.
05/24/2021 2:42:25 PM
The only reasons I see to buy NUGX
GNBTQ Generex Biotechnology Corp.
05/21/2021 5:44:35 PM
Yes, I know that the conversion is (1)
GNBTQ Generex Biotechnology Corp.
05/21/2021 2:41:48 PM
Thanks Bravo16. I wondered the same
GNBTQ Generex Biotechnology Corp.
05/21/2021 2:14:27 PM
I don't think that it is the same t
GNBTQ Generex Biotechnology Corp.
05/21/2021 10:59:58 AM
I am also interested in the price o
GNBTQ Generex Biotechnology Corp.
05/21/2021 8:25:42 AM
I don't mind to be wrong but just t (2)
GNBTQ Generex Biotechnology Corp.
05/20/2021 11:55:30 PM
I forgot the share price in the cal (1)
GNBTQ Generex Biotechnology Corp.
05/20/2021 8:42:26 PM
I have really a problem understandi
GNBTQ Generex Biotechnology Corp.
05/19/2021 6:44:24 PM
I think the same, the market may no
GNBTQ Generex Biotechnology Corp.
05/18/2021 1:32:59 PM
"we're filing the IND by the end of (4)
GNBTQ Generex Biotechnology Corp.
05/13/2021 6:20:00 PM
I looked at the CC transcript and a (1)
GNBTQ Generex Biotechnology Corp.
05/10/2021 6:02:16 PM
I also understood that they could s (2)
GNBTQ Generex Biotechnology Corp.
04/28/2021 3:33:26 PM
I feel like GNBT is all-in with the (2)
GNBTQ Generex Biotechnology Corp.
04/24/2021 5:37:39 AM
Even more knowing that IBRX aims at (1)
GNBTQ Generex Biotechnology Corp.
03/18/2021 5:27:36 PM
I didn't get any share dividend, I
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >
Deliver breaking news, insightful commentary, and exclusive reports. Get in touch benzingaheadline@gmail.com. Target readers who trust our platform to stay ahead of the curve.

Recent Articles

  • GlocalMe Unveils Innovative Solutions at Major Tech Expo
  • Investors Have a Unique Opportunity for Recovery with CTO Realty
  • Picasso Print DTF Increases Production by 130% with AI Technology
  • Rosen Law Firm Investigates Disney for Children's Privacy Concerns
  • Understanding Unclaimed Lottery Winnings: Powerball Insights
  • TCL Achieves Milestone in Mini LED Market Share Growth
  • GlocalMe Unveils Innovative Connectivity Solutions at IFA 2025
  • John Monsky's Impactful Multisensory Performance for Kids
  • Investors Urged to Lead Class Action Against Altimmune, Inc.
  • Critical Guidance for Fiserv, Inc. Investors Facing Losses
  • Encaleret Demonstrates Exciting Results for Calcium Normalization
  • Federal Court Upholds Immigration Protections for TPS Holders
  • Harnessing Executive Function Coaching for Long-Term Success
  • CIGA Design's Innovative Eco-Friendly Candles at Paris Fair
  • Hisense Celebrates Innovation with Nine Awards in 2025
  • Justin Sun's Dilemma with World Liberty's Token Freeze
  • Hisense Revolutionizes Home Entertainment with Cutting-Edge Tech
  • LifeMD Investors: Your Chance to Join the Securities Class Action
  • Robinhood's Landmark Inclusion in S&P 500: A New Era for Retail Investing
  • Important Update for Nutex Health Investors and Legal Rights
  • Faruqi Firm Investigates Fiserv Investors Ahead of Deadline
  • Urgent Notice for Semler Scientific Investors on Legal Actions
  • TESSAN Enhances Brand Identity with Unique Experience at IFA
  • Investors Alert: Investigating Lockheed Martin Claims for Recovery
  • Kao Collins Unveils Innovative XBAR Printhead for Businesses
  • Insights on Trump Administration's Week 33: Key Developments
  • TCL Unveils Innovative Technology at IFA, Celebrates Olympic Spirit
  • A Recap of Week 33 under Trump's Leadership and Policies
  • BioMarin Shares Exciting New PALYNZIQ Data at Global Metabolism Event
  • Revolutionary Display and Sound Technologies from Hisense
  • Changhong Unveils Innovative Panda-Inspired Tech at IFA
  • Roblox Corporation Faces Legal Scrutiny Amid Allegations
  • SuperX AI Faces Scrutiny Amid Allegations of Misrepresentation
  • Investors Urged to Act: Replimune Class Action Insight
  • Charter Communications Investors: Join the Class Action Today
  • Exploring the Digital Health Market: Growth and Innovations Ahead
  • Understanding the LifeMD Class Action Lawsuit and What It Means
  • Pomerantz Law Firm Investigates Potential Securities Fraud Claims
  • Exploring the Growth of the Virtual Production Market by 2030
  • Understanding the Securities Investigation of Six Flags Corp
  • Novo Nordisk A/S Investors Urged to Act Before Deadline
  • Critical Investor Alert: Novo Nordisk Claims Under Review
  • TCL Mobile's Breakthrough in Eye-Care Display Technology
  • Growing Opportunities in Antibody Discovery Market
  • Investors of PubMatic, Inc. Urged to Join Class Action Lawsuit
  • Investigation into EHang Holdings: What Investors Need to Know
  • Pomerantz Firm Investigates NeoGenomics Investor Claims
  • Investor Insights: Lineage, Inc. Faces Scrutiny Over Securities
  • Investigation of Marex Group PLC Raises Significant Concerns
  • Pomerantz Law Firm Investigates Valneva SE for Investors
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site